These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 30586597)
1. Macrophage entrapped silica coated superparamagnetic iron oxide particles for controlled drug release in a 3D cancer model. Ullah S; Seidel K; Türkkan S; Warwas DP; Dubich T; Rohde M; Hauser H; Behrens P; Kirschning A; Köster M; Wirth D J Control Release; 2019 Jan; 294():327-336. PubMed ID: 30586597 [TBL] [Abstract][Full Text] [Related]
2. Triple Therapy of HER2 Zolata H; Afarideh H; Davani FA Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759 [TBL] [Abstract][Full Text] [Related]
3. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent. Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545 [TBL] [Abstract][Full Text] [Related]
4. Investigation of magnetic silica with thermoresponsive chitosan coating for drug controlled release and magnetic hyperthermia application. Pon-On W; Tithito T; Maneeprakorn W; Phenrat T; Tang IM Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():23-30. PubMed ID: 30678907 [TBL] [Abstract][Full Text] [Related]
5. Spatial, Temporal, and Dose Control of Drug Delivery using Noninvasive Magnetic Stimulation. Chen W; Cheng CA; Zink JI ACS Nano; 2019 Feb; 13(2):1292-1308. PubMed ID: 30633500 [TBL] [Abstract][Full Text] [Related]
6. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050 [TBL] [Abstract][Full Text] [Related]
7. Triggered release in lipid bilayer-capped mesoporous silica nanoparticles containing SPION using an alternating magnetic field. Bringas E; Köysüren Ö; Quach DV; Mahmoudi M; Aznar E; Roehling JD; Marcos MD; Martínez-Máñez R; Stroeve P Chem Commun (Camb); 2012 Jun; 48(45):5647-9. PubMed ID: 22543447 [TBL] [Abstract][Full Text] [Related]
8. Nanomachines and Other Caps on Mesoporous Silica Nanoparticles for Drug Delivery. Chen W; Glackin CA; Horwitz MA; Zink JI Acc Chem Res; 2019 Jun; 52(6):1531-1542. PubMed ID: 31082188 [TBL] [Abstract][Full Text] [Related]
9. Multifunctional magnetic silica nanotubes for MR imaging and targeted drug delivery. Huang L; Ao L; Wang W; Hu D; Sheng Z; Su W Chem Commun (Camb); 2015 Mar; 51(18):3923-6. PubMed ID: 25656155 [TBL] [Abstract][Full Text] [Related]
10. Biodegradable Magnetic Silica@Iron Oxide Nanovectors with Ultra-Large Mesopores for High Protein Loading, Magnetothermal Release, and Delivery. Omar H; Croissant JG; Alamoudi K; Alsaiari S; Alradwan I; Majrashi MA; Anjum DH; Martins P; Laamarti R; Eppinger J; Moosa B; Almalik A; Khashab NM J Control Release; 2017 Aug; 259():187-194. PubMed ID: 27913308 [TBL] [Abstract][Full Text] [Related]
11. Nucleus-targeted nano delivery system eradicates cancer stem cells by combined thermotherapy and hypoxia-activated chemotherapy. Li H; Yan W; Suo X; Peng H; Yang X; Li Z; Zhang J; Liu D Biomaterials; 2019 Apr; 200():1-14. PubMed ID: 30743049 [TBL] [Abstract][Full Text] [Related]
12. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect. Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697 [TBL] [Abstract][Full Text] [Related]
13. Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging. Chiang WH; Huang WC; Chang CW; Shen MY; Shih ZF; Huang YF; Lin SC; Chiu HC J Control Release; 2013 Jun; 168(3):280-8. PubMed ID: 23562635 [TBL] [Abstract][Full Text] [Related]
14. Preparation, Characterization, and In Vitro pH-sensitivity Evaluation of Superparamagnetic Iron Oxide Nanoparticle- Misonidazole pH-sensitive Liposomes. Li B; Li B; He D; Feng C; Luo Z; He M Curr Drug Deliv; 2019; 16(3):254-267. PubMed ID: 30426901 [TBL] [Abstract][Full Text] [Related]
15. Biotechnological approach to induce human fibroblast apoptosis using superparamagnetic iron oxide nanoparticles. Ferraz FS; López JL; Lacerda SMSN; Procópio MS; Figueiredo AFA; Martins EMN; Guimarães PPG; Ladeira LO; Kitten GT; Dias FF; Domingues RZ; Costa GMJ J Inorg Biochem; 2020 May; 206():111017. PubMed ID: 32120160 [TBL] [Abstract][Full Text] [Related]
16. Differential effect of polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles on BT-474 human breast cancer cell viability. Aliakbari M; Mohammadian E; Esmaeili A; Pahlevanneshan Z Toxicol In Vitro; 2019 Feb; 54():114-122. PubMed ID: 30266435 [TBL] [Abstract][Full Text] [Related]
17. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles). Wu VM; Huynh E; Tang S; Uskoković V Acta Biomater; 2019 Apr; 88():422-447. PubMed ID: 30711662 [TBL] [Abstract][Full Text] [Related]
18. Biocompatible superparamagnetic sub-micron vaterite particles for thermo-chemotherapy: From controlled design to in vitro anticancer synergism. Choukrani G; Maharjan B; Park CH; Kim CS; Kurup Sasikala AR Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110226. PubMed ID: 31753366 [TBL] [Abstract][Full Text] [Related]
19. Magnetic mesoporous silica nanoparticles for potential delivery of chemotherapeutic drugs and hyperthermia. Tao C; Zhu Y Dalton Trans; 2014 Nov; 43(41):15482-90. PubMed ID: 25190592 [TBL] [Abstract][Full Text] [Related]